Photocarcinogenic risks of narrowband ultraviolet B therapy and psoralen + ultraviolet A therapy

Introduction: Narrowband UVB Therapy and Psoralen + UVA therapy are widely used in the treatment of several skin disorders. Although short-term security has been demonstrated, there are several concerns about long term security and, in particular, the risk of skin cancer after NB-UVB and PUVA therapy.